Q3 2024 Holdings
Filed 2024-11-14 | 22 holdings | $166.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Genedx Holdings Corp(WGS) | COM CL A | 81663L200 | $44.4M | 1,045,768 | 26.6% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $35.2M | 705,250 | 21.1% |
| Biohaven LTD(BHVN)Call | CALL | G1110E907 | $15.1M | 302,700 | 9.1% |
| Phathom Pharmaceuticals Inc(PHAT) | COM | 71722W107 | $13.6M | 749,487 | 8.1% |
| Spdr SER TRCall | CALL | 78464A900 | $9.9M | 100,000 | 5.9% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $9.4M | 1,369,200 | 5.7% |
| Novavax IncCall | CALL | 670002901 | $6.8M | 534,600 | 4.0% |
| Quidelortho Corp(QDEL) | COM | 219798105 | $5.4M | 118,291 | 3.2% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $4.1M | 535,558 | 2.4% |
| Myriad Genetics Inc(MYGN) | COM | 62855J104 | $3.7M | 134,500 | 2.2% |
| Phathom Pharmaceuticals IncCall | CALL | 71722W907 | $3.5M | 192,700 | 2.1% |
| Ardelyx IncCall | CALL | 039697907 | $3.0M | 430,200 | 1.8% |
| Forian Inc(FORA) | COM | 34630N106 | $2.9M | 1,356,107 | 1.8% |
| Eyepoint Pharmaceuticals IncCall | CALL | 30233G909 | $2.8M | 350,000 | 1.7% |
| Cava Group Inc(CAVA) | COM | 148929102 | $2.3M | 18,600 | 1.4% |
| Pacific Biosciences Calif in(PACB) | COM | 69404D108 | $1.2M | 727,877 | 0.7% |
| Springworks Therapeutics Inc | COM | 85205L107 | $1.1M | 34,200 | 0.7% |
| Palantir Technologies Inc(PLTR) | CL A | 69608A108 | $1.0M | 27,500 | 0.6% |
| Palantir Technologies IncCall | CALL | 69608A908 | $744.0K | 20,000 | 0.4% |
| Biogen Inc(BIIB) | COM | 09062X103 | $467.5K | 2,412 | 0.3% |
| Eyepoint Pharmaceuticals Inc(EYPT) | COM NEW | 30233G209 | $259.7K | 32,500 | 0.2% |
| Biodesix Inc | COM | 09075X108 | $51.5K | 28,916 | 0.0% |